Global Polymerase Chain Reaction (PCR) Devices Market Segmentation, By Technology (Digital PCR, Real-time PCR), Product Type (Instrument, Reagent, Consumables, Others), Application (Oncology, Blood Testing, Pathogen Detection, Research, Forensic, Others), End-User (Hospital, Diagnostic Center, Pharmaceutical and Biotechnology Companies, Clinical Research Organizations, Academia, Laboratories) – Industry Trends and Forecast to 2031.
Polymerase Chain Reaction (PCR) Devices Market Analysis
Over recent years, the personalized medicine, which strives to give individual patients with tailored therapies based on the biological basis of disease, has gained immense popularity. A major aspect driving market expansion is the rising desire for personalized and precise treatment. In pharmaceutical and biotechnology research as well as microbiological quality control, the polymerase chain reaction (PCR) method has shown immense growth. These determinants will aid in growth of the polymerase chain reaction (PCR) devices market.
Polymerase Chain Reaction (PCR) Devices Market Size
Global polymerase chain reaction (PCR) devices market size was valued at USD 25.34 billion in 2023 and is projected to reach USD 30.64 billion by 2031, with a CAGR of 2.40% during the forecast period of 2024 to 2031.
Report Scope and Market Segmentation
|
Attributes
|
Polymerase Chain Reaction (PCR) Devices Key Market Insights
|
|
Segmentation
|
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
|
|
Key Market Players
|
Medtronic (Ireland), B.D. (U.S.), Abbott (U.S.), Johnson & Johnson Private Limited (U.S.), Stryker (U.S.), Osseon LLC. (U.S.), Alphatec Spine, Inc. (U.S.), G21 S.r.l. (Italy), Globus Medical (U.S.), SOMATEX Medical Technologies GmbH (Germany), Parallax health Sciences, Inc. (U.S.), Merit Medical Systems (USA), RONTIS (Switzerland), ZAVATION (U.S.), IZI Medical Products (U.S.), Teknimed (France), BPB medica (Italy), Cook (US), Zimmer Biomet (U.S.)
|
Polymerase Chain Reaction (PCR) Devices Market Definition
Polymerase chain reaction (PCR) devices, also referred to as thermal cycler, are commonly used in laboratories to amplify DNA segments through polymerase chain reaction. Cloning, DNA sequencing, library building, mutagenesis, and expression profiling are just a few of the applications for PCR instruments.
Polymerase Chain Reaction (PCR) Devices Market Dynamics
This section deals with understanding the market drivers, advantages, opportunities, restraints and challenges. All of this is discussed in detail as below:
Drivers
- Increased Demand For Polymerase Chain Reaction (PCR) Devices To Bolster Growth
The surging application in clinical diagnostics, rise in the usage of biomarkers for diagnosis of diseases infants, and rising demand for personalized and precision medicine are the most significant factors driving the growth for this market.
- Growing Health Issues
Surging incidences of infectious diseases and genetic disorders infants, which further accelerate adoption of polymerase chain reaction (PCR) devices, are expected to accelerate the market's overall growth.
Furthermore, the increasing demand for advanced diagnostic techniques, the expanding healthcare sector, and the rising technological advancement to adopt the new technology in PCR devices infants are also expected to fuel market growth. Moreover, the rising awareness among the patients and doctors regarding the chronic diseases and hospital-acquired infections also cushions the market’s growth within the forecasted period. The surging number of CROs, forensic and research laboratories owing to their automation, real-time quantification, precision, accuracy, and sensitivity are also projected to bolster the growth of the market.
Opportunities
- Growing Investments and Advancements
Moreover, the rising public and private investments are estimated to generate lucrative opportunities for the market. The increasing technological advancements and modernization in the healthcare devices and rising research and development activities will further offer numerous growth opportunities for the market.
Restraints/Challenges
- Lack of Knowledge and Awareness
The dearth of knowledge and awareness regarding the polymerase chain reaction (PCR) devices in emerging economies is expected to obstruct market growth.
- Dearth of Professionals Will Pose as a Challenge
Also, the shortage of skilled healthcare professionals or lack of trained experts are projected to challenge the polymerase chain reaction (PCR) devices market in the forecast period of 2024-2031.
This polymerase chain reaction (PCR) devices market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the polymerase chain reaction (PCR) devices market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Post Covid-19 Impact on Polymerase Chain Reaction (PCR) Devices Market
The polymerase chain reaction (PCR) devices market was largely impacted by the outbreak of COVID-19. The global outbreak of the coronavirus epidemic has boosted the demand for accurate and quick detection techniques like qPCR, owing to its better specificity and sensitivity than other tests, it is the gold standard for detecting the new coronavirus. The development of RT-qPCR kits that can identify SARS-CoV-2, as well as their widespread acceptance around the world. The combination of digital PCR and group testing procedures is expected to lower costs and increase testing capacity, which is estimated to impact the market positively.
Moreover, the majority of pharmaceutical and biotech industries are concentrating their research and development efforts on finding novel compounds or leads to treat COVID-19. The surging demand in the clinical diagnostic area of the industry has a positive impact on the market as the government does not authorize viral culture tests, practically all diagnostic tests use RT-PCR to test people who have COVID-19 symptoms and are urged by healthcare providers to get tested.
Therefore, the increased product demand had a positive impact on the market.
Polymerase Chain Reaction (PCR) Devices Market Scope
The polymerase chain reaction (PCR) devices market is segmented on the basis of technology, product type, application and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Technology
- Digital PCR
- Real-time PCR
Product Type
- Instrument
- Reagent
- Consumables
- Others
Application
- Oncology
- Blood Testing
- Pathogen Detection
- Research
- Forensic
- Others
End User
- Hospital
- Diagnostic Center
- Pharmaceutical and Biotechnology Companies
- Clinical Research Organizations
- Academia
- Laboratories
Polymerase Chain Reaction (PCR) Devices Market Regional Analysis
The polymerase chain reaction (PCR) devices market is analyzed and market size insights and trends are provided by country, technology, product type, application and end-user as referenced above.
The countries covered in the polymerase chain reaction (PCR) devices market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the polymerase chain reaction (PCR) devices market because of the region's rising favorable government initiatives and flexible regulatory guidelines.
Asia-Pacific is expected to witness significant growth during the forecast period of 2024 to 2031 due to the rising awareness among patients about early diagnosis of these diseases and increase in the patient pool due to the high prevalence of chronic and infectious diseases within the region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Polymerase Chain Reaction (PCR) Devices Market Share
The polymerase chain reaction (PCR) devices market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to polymerase chain reaction (PCR) devices market.
Polymerase Chain Reaction (PCR) Devices Market Leaders Operating in the Market Are:
- Abbott (U.S.)
- bioMérieux (France)
- BD (U.S.)
- Danaher (U.S.)
- Thermo Fisher Scientific Inc (U.S.)
- Siemens (Germany)
- Agilent Technologies, Inc (U.S.)
- Merck KGaA (Germany)
- Fluidigm (U.S.)
- QIAGEN (Germany)
- Bio-Rad Laboratories, Inc (U.S.)
- Cytiva (U.S.)
- Stryker (U.S.)
- Johnson & Johnson Private Limited (U.S.)
- Smith+Nephew (U.K.)
- Bruker (U.S.)
Latest Developments in Polymerase Chain Reaction (PCR) Devices Market
- In July 2021, PathStore declared the unveiling of the COVID-19 RT-PCR test in India at the lowest price compared to other companies. This quick test aims to get the most out of COVID-19 diagnosis in order to ensure timely treatment.
SKU-